Insider Trading & Ownership - Vivos Therapeutics Inc. (VVOS)

Real time insider trading transaction history:

  • Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
  • Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Insider Trading Transactions for Vivos Therapeutics Inc.
Goto 0, 1, Next
Common stock purchase or sale:
Transaction
Date		 Reported
DateTime		 Company Symbol Insider
Relationship		 Shares
Traded		 Average
Price		 Total
Amount		 Shares
Owned		 Filing
2023-06-20
Purchase		 2023-06-20
9:58 pm		 Vivos Therapeutics Inc. VVOS Huntsman Ronald Kirk
Chief Executive Officer		 14,000 $0.53 $7,420 1,826,521
(Indirect
Direct)		 View
2023-06-15
Purchase		 2023-06-20
06:10 am		 Vivos Therapeutics Inc. VVOS Huntsman Ronald Kirk
Chief Executive Officer		 15,021 $0.53662 $8,061 1,812,521
(Indirect
Direct)		 View
2023-06-14
Purchase		 2023-06-15
7:15 pm		 Vivos Therapeutics Inc. VVOS Huntsman Ronald Kirk
Chief Executive Officer		 10,000 $0.49 $4,900 1,797,500
(Indirect
Direct)		 View
2022-12-23
Purchase		 2022-12-28
9:45 pm		 Vivos Therapeutics Inc. VVOS Huntsman Ronald Kirk
Chief Executive Officer
10% Owner		 20,000 $0.5 $10,000 2,604,168
(Indirect
Direct)		 View
2022-05-31
Purchase		 2022-06-03
06:08 am		 Vivos Therapeutics Inc. VVOS Huntsman Ronald Kirk
Chief Executive Officer
10% Owner		 12,000 $1.9633 $23,560 1,767,500
(Indirect
Direct)		 View
2021-09-21
Purchase		 2021-09-22
3:09 pm		 Vivos Therapeutics Inc. VVOS Huntsman Ronald Kirk
Chief Executive Officer		 5,000 $4.31 $21,550 2,088,834
(Indirect
Direct)		 View
2021-08-17
Purchase		 2021-08-18
3:47 pm		 Vivos Therapeutics Inc. VVOS Huntsman Ronald Kirk
Chief Executive Officer		 5,000 $3 $15,000 2,083,834
(Indirect
Direct)		 View
2021-05-25
Purchase		 2021-05-25
9:45 pm		 Vivos Therapeutics Inc. VVOS Amman Bradford K.
Chief Financial Officer		 1,000 $5.29 $5,290 202,001
(Direct)		 View
2021-05-25
Purchase		 2021-05-25
9:45 pm		 Vivos Therapeutics Inc. VVOS Huntsman Ronald Kirk
Chief Executive Officer		 4,000 $5.38 $21,520 2,087,834
(Indirect
Direct)		 View
2020-12-24
Purchase		 2020-12-28
06:21 am		 Vivos Therapeutics Inc. VVOS Amman Bradford K.
Chief Financial Officer		 1,000 $7.38 $7,380 101,001
(Direct)		 View
2020-12-23
Purchase		 2020-12-23
6:53 pm		 Vivos Therapeutics Inc. VVOS Huntsman Ronald Kirk
Chief Executive Officer
10% Owner		 1,000 $7.2669 $7,267 2,083,834
(Indirect
Direct)		 View
2020-12-11
Purchase		 2020-12-14
08:45 am		 Vivos Therapeutics Inc. VVOS Huntsman Ronald Kirk
Chief Executive Officer
10% Owner		 500 $8.5 $4,250 2,082,834
(Indirect
Direct)		 View

Stock options: Exercise, Award, Grant, Conversion
Transaction
Date		 Reported
DateTime		 Exercisable
Expiration		 Company Symnbol Insider
Relationship		 Shares
Traded		 Conversion
Price		 Shares
Owned		 Filing
2024-11-26
Option Award		 2024-11-27
4:47 pm		 N/A
2034-09-07		 Vivos Therapeutics Inc. VVOS Huntsman Ronald Kirk
Chief Executive Officer		 315,421 $2.64 437,816
(Direct)		 View
2024-11-26
Option Award		 2024-11-27
4:43 pm		 N/A
2034-09-07		 Vivos Therapeutics Inc. VVOS Amman Bradford K.
Chief Financial Officer		 149,533 $2.64 180,613
(Direct)		 View
2024-06-20
Option Award		 2024-06-28
8:53 pm		 N/A
2029-06-20		 Vivos Therapeutics Inc. VVOS Huntsman Ronald Kirk
Chief Executive Officer		 20,000 $2.38 122,395
(Direct)		 View
2024-06-20
Option Award		 2024-06-28
8:53 pm		 N/A
2029-06-20		 Vivos Therapeutics Inc. VVOS SOKOLOW LEONARD J
Director		 4,000 $2.38 7,467
(Direct)		 View
2024-06-20
Option Award		 2024-06-28
8:53 pm		 N/A
2029-06-20		 Vivos Therapeutics Inc. VVOS Thompson Matthew
Director		 4,000 $2.38 7,067
(Direct)		 View
2024-06-20
Option Award		 2024-06-28
8:53 pm		 N/A
2029-06-20		 Vivos Therapeutics Inc. VVOS Krammer Anja B
Director		 4,000 $2.38 7,067
(Direct)		 View
2024-06-20
Option Award		 2024-06-28
8:53 pm		 N/A
2029-06-20		 Vivos Therapeutics Inc. VVOS Green Ralph Elias
Director		 4,000 $2.38 7,067
(Direct)		 View
2024-06-20
Option Award		 2024-06-28
8:53 pm		 N/A
2029-06-20		 Vivos Therapeutics Inc. VVOS Lindsay Mark F.
Director		 4,000 $2.38 7,067
(Direct)		 View
2024-06-20
Option Award		 2024-06-28
8:53 pm		 N/A
2029-06-20		 Vivos Therapeutics Inc. VVOS Amman Bradford K.
Chief Financial Officer		 15,000 $2.38 31,747
(Direct)		 View
2022-12-23
Option Award		 2022-12-28
9:45 pm		 N/A
2027-12-23		 Vivos Therapeutics Inc. VVOS Krammer Anja B
Director		 30,000 $0.48 76,667
(Direct)		 View
2022-12-23
Option Award		 2022-12-28
9:45 pm		 N/A
2027-12-23		 Vivos Therapeutics Inc. VVOS SOKOLOW LEONARD J
Director		 30,000 $0.48 76,667
(Direct)		 View
2022-12-23
Option Award		 2022-12-28
9:45 pm		 N/A
2027-12-23		 Vivos Therapeutics Inc. VVOS Thompson Matthew
Director		 30,000 $0.48 76,667
(Direct)		 View
2022-12-23
Option Award		 2022-12-28
9:45 pm		 N/A
2027-12-23		 Vivos Therapeutics Inc. VVOS Huntsman Ronald Kirk
Chief Executive Officer
10% Owner		 483,334 $0.48 2,604,168
(Direct)		 View
2022-12-23
Option Award		 2022-12-28
9:45 pm		 N/A
2027-12-23		 Vivos Therapeutics Inc. VVOS Lindsay Mark F.
Director		 30,000 $0.48 76,667
(Direct)		 View
2022-12-23
Option Award		 2022-12-28
9:45 pm		 N/A
2027-12-23		 Vivos Therapeutics Inc. VVOS Amman Bradford K.
Chief Financial Officer		 200,000 $0.48 500,001
(Direct)		 View
2022-12-23
Option Award		 2022-12-28
9:45 pm		 N/A
2027-12-23		 Vivos Therapeutics Inc. VVOS Green Ralph Elias
Director		 30,000 $0.48 76,667
(Direct)		 View
2022-02-25
Option Award		 2022-02-28
6:54 pm		 N/A
2027-02-25		 Vivos Therapeutics Inc. VVOS Huntsman Ronald Kirk
Chief Executive Officer		 125,000 $3.27 125,000
(Direct)		 View
2022-02-25
Option Award		 2022-02-28
6:50 pm		 N/A
2027-02-25		 Vivos Therapeutics Inc. VVOS Amman Bradford K.
Chief Financial Officer		 50,000 $3.27 50,000
(Direct)		 View
2021-06-16
Ownership		 2022-02-14
9:21 pm		 N/A
2026-06-26		 Vivos Therapeutics Inc. VVOS Huntsman Ronald Kirk
Chief Executive Officer		 125,000 $5.64 125,000
(Direct)		 View
2021-03-12
Option Award		 2021-09-02
9:27 pm		 N/A
2026-03-12		 Vivos Therapeutics Inc. VVOS Amman Bradford K.
Chief Financial Officer		 200,001 $7.5 252,001
(Direct)		 View
2021-08-31
Option Award		 2021-09-02
9:27 pm		 N/A
2026-08-31		 Vivos Therapeutics Inc. VVOS Amman Bradford K.
Chief Financial Officer		 50,000 $5.26 252,001
(Direct)		 View
2021-08-05
Option Award		 2021-08-10
9:49 pm		 N/A
2026-08-05		 Vivos Therapeutics Inc. VVOS Thompson Matthew
Director		 30,000 $2.72 46,667
(Direct)		 View
2021-08-05
Option Award		 2021-08-10
9:47 pm		 N/A
2026-08-05		 Vivos Therapeutics Inc. VVOS Green Ralph Elias
Director		 30,000 $2.72 46,667
(Direct)		 View
2021-08-05
Option Award		 2021-08-10
9:46 pm		 N/A
2026-08-05		 Vivos Therapeutics Inc. VVOS Krammer Anja B
Director		 30,000 $2.72 46,667
(Direct)		 View
2021-08-05
Option Award		 2021-08-10
9:44 pm		 N/A
2026-08-05		 Vivos Therapeutics Inc. VVOS Singh Gurdev Dave
Chief Medical Officer
10% Owner		 30,000 $2.72 3,266,372
(Direct)		 View
2021-08-05
Option Award		 2021-08-10
9:43 pm		 N/A
2026-08-05		 Vivos Therapeutics Inc. VVOS Lindsay Mark F.
Director		 30,000 $2.72 46,667
(Direct)		 View
2021-08-05
Option Award		 2021-08-10
9:41 pm		 N/A
2026-08-05		 Vivos Therapeutics Inc. VVOS SOKOLOW LEONARD J
Director		 30,000 $2.72 46,667
(Direct)		 View

Ownership(A)		 2021-06-29
4:18 pm		 N/A
N/A		 Vivos Therapeutics Inc. VVOS Huntsman Ronald Kirk
Chairman and CEO
10% Owner		 0 $0 1,740,000
(Indirect)		 View
2021-03-12
Option Award		 2021-03-17
8:48 pm		 N/A
2026-03-12		 Vivos Therapeutics Inc. VVOS Amman Bradford K.
Chief Financial Officer		 100,000 $7.5 201,001
(Direct)		 View

Ownership		 2020-12-10
9:55 pm		 N/A
2025-06-19		 Vivos Therapeutics Inc. VVOS SOKOLOW LEONARD J
Director		 0 $0 16,667
(Direct)		 View
(A) Indicate amendment filing.
Goto 0, 1, Next